menu
    • menu

    Company profile for Accro Bioscience

    NEW Drugs in Dev: 3
    Minakem delivers API, HPAPI, steroids & CDMO services for generics with FDA/GMP certification, regulatory know-how & proven success.

    Virtual Booth

    Contact Supplier

    Boai NKY Pharmaceuticals Ltd. is one of the largest global PVP suppliers.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    Nanjing Well is focused on R&D, production & sales of Pharmaceutical Excipients & Synthetic Lubricating base oils.

    Virtual Booth

    Contact Supplier

    Ever Pharma, highly specialized CDMO in producing complex injectables including high potency & controlled substances, suspensions, etc.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    At the end of 2017, a group of industrial veterans and scientists with decades of experience in drug research and development established Accro Bioscience (Suzhou) Limited. Wholly owned by Accro Bioscience (HK) Limited, Accro Bioscience (Suzhou) Limited is a clinical-stage biotech company with a core focus on molecular mechanisms of regulated cell death and related pathogenesis in human diseases. Through harnessing the power o...
    At the end of 2017, a group of industrial veterans and scientists with decades of experience in drug research and development established Accro Bioscience (Suzhou) Limited. Wholly owned by Accro Bioscience (HK) Limited, Accro Bioscience (Suzhou) Limited is a clinical-stage biotech company with a core focus on molecular mechanisms of regulated cell death and related pathogenesis in human diseases. Through harnessing the power of science and drug discovery, the Company has developed a robust portfolio with innovative compounds in various stages spanning from lead optimization to clinical trials.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Accro BioscienceChina Flag
    Country
    Country
    China
    Address
    Address
    Unit E37, North Building A1, BioBay, No.218 Xinghu Street, Suzhou Industrial P...
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    http://www.accro.com.cn/en/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    PEGS Boston Summit

    PEGS Boston Summit

    Not Confirmed

    envelop Contact Supplier

    PEGS Boston Summit

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Accro Bioscience Raises $50M Series C Led by OrbiMed
    Accro Bioscience Raises $50M Series C Led by OrbiMed

    19 May 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/accro-bioscience-announces-50-million-series-c-financing-led-by-orbimed-to-advance-clinical-pipeline-for-immune-mediated-diseases-302774824.html

    PR NEWSWIRE
    19 May 2026
    Share Share
    Full-Life Raises $150M; Quince Reboots with Pulmonary Drug
    Full-Life Raises $150M; Quince Reboots with Pulmonary Drug

    19 May 2026

    // ENDPOINTS

    https://endpoints.news/full-life-technologies-raises-150m-quince-finds-a-new-life/

    ENDPOINTS
    19 May 2026
    Share Share
    Accro Grant Fosun Pharma Exclusive Rights for TYK2/JAK1 Inhibitor
    Accro Grant Fosun Pharma Exclusive Rights for TYK2/JAK1 Inhibitor

    29 Aug 2025

    // CONTRACTPHARMA

    https://www.contractpharma.com/breaking-news/accro-bioscience-grants-fosun-pharma-exclusive-rights-for-tyk2-jak1-inhibitor-in-greater-china/

    CONTRACTPHARMA
    29 Aug 2025
    Share Share
    Accropeutics Reports Positive Phase 2 Data for AC-201 in Psoriasis
    Accropeutics Reports Positive Phase 2 Data for AC-201 in Psoriasis

    20 May 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/accropeutics-announces-positive-data-from-phase-2-trial-of-ac-201-an-oral-selective-tyk2jak1-inhibitor-for-the-treatment-of-moderate-to-severe-plaque-psoriasis-302461241.html

    PR NEWSWIRE
    20 May 2025
    Share Share
    Blueprint Medicines Reports Q4 and Full Year 2024 Results
    Blueprint Medicines Reports Q4 and Full Year 2024 Results

    13 Feb 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/blueprint-medicines-reports-fourth-quarter-and-full-year-2024-results-302375527.html

    PR NEWSWIRE
    13 Feb 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search